MDMA in Borderline Personality Disorder

Clinical trial NCT06683014 · RECRUITING

Trial details

NCT number: NCT06683014
Sponsor: Yale University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Borderline Personality Disorder

Start date: 2025-09-05
Primary completion: 2026-09-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.